Explore

Vascular Dementia: Recognizing Symptoms and Managing Risks

Vascular Dementia: Recognizing Symptoms and Managing Risks

Vascular dementia is characterized by cognitive decline due to reduced blood flow to the brain, often following strokes or chronic small vessel damage. Symptoms include slowed thinking, attention difficulties, and impaired judgment, which can appear suddenly or develop gradually. Diagnosis involves medical history, cognitive testing, and brain imaging. Treatment focuses on managing vascular risk factors like high blood pressure and diabetes to slow progression and maintain independence. Supportive care, including occupational therapy and structured routines, is crucial for improving quality of life.

New Theory Suggests Infection May Be Linked to Alzheimer's Disease

New Theory Suggests Infection May Be Linked to Alzheimer's Disease

A new theory suggests that Alzheimer's disease may be linked to an infection caused by the bacterium Porphyromonas gingivalis, commonly associated with gum disease. Researchers have found this bacterium in the brains of Alzheimer's patients, challenging the traditional view of the disease as solely a neurodegenerative condition. The discovery raises the possibility that oral hygiene could play a role in preventing Alzheimer's, as the bacterium may enter the brain through the bloodstream. This theory is supported by studies showing increased beta-amyloid proteins in mice infected with the bacterium.

Study Links Multimorbidity to Cognitive Decline and Alzheimer's Biomarkers in U.S. Adults

Study Links Multimorbidity to Cognitive Decline and Alzheimer's Biomarkers in U.S. Adults

A study involving 3,808 dementia-free participants from the Health and Aging Brain Study: Health Disparities has found that a higher burden of multimorbidity is associated with worse cognitive function and increased levels of Alzheimer's disease biomarkers. The research, conducted by a team from various U.S. institutions, assessed the impact of multiple chronic conditions on cognition and biomarkers related to Alzheimer's pathology, neurodegeneration, and cerebral small vessel disease. The study highlights the complex relationship between multimorbidity and cognitive decline, emphasizing the need for a holistic approach to managing chronic diseases to potentially delay cognitive deterioration.

COVID-19 Linked to Structural Brain Changes, Study Finds

COVID-19 Linked to Structural Brain Changes, Study Finds

A comprehensive review of 49 brain imaging studies has revealed that COVID-19 is associated with significant structural and functional changes in the brain. The research, published in the journal Cerebral Cortex, indicates that the virus affects areas responsible for memory, emotion, and executive function. These findings help explain the neurological symptoms reported by many patients, such as brain fog and memory loss. The study synthesized data from various medical studies using magnetic resonance imaging to map the brain's anatomy and activity, identifying consistent patterns of abnormalities in key brain regions.

New Study Confirms Adult Human Brain's Ability to Generate Neurons, Challenging Long-Held Beliefs

New Study Confirms Adult Human Brain's Ability to Generate Neurons, Challenging Long-Held Beliefs

A recent study published in the journal Science has provided compelling evidence that the adult human brain can generate new neurons, a process known as neurogenesis. This finding challenges the long-standing belief that humans are born with a finite number of neurons. Researchers utilized advanced technologies, including single-cell RNA sequencing and artificial intelligence, to examine the hippocampus, a critical brain region for memory and learning. The study analyzed over 400,000 cell nuclei from individuals ranging from newborns to 78 years old. The results indicate that neurogenesis continues into adulthood, except in individuals with Alzheimer's disease. This discovery could have significant implications for understanding neurodegenerative diseases and cognitive potential throughout life.

Study Links Excessive TV Watching to Reduced Brain Volume and Cognitive Decline

Study Links Excessive TV Watching to Reduced Brain Volume and Cognitive Decline

A recent study has found a correlation between heavy television viewing in midlife and reduced brain volumes in later years, particularly in areas associated with language and cognitive control. The research, which analyzed data from over 1,700 participants, revealed that those who reported watching television 'very often' had smaller brain volumes and more white matter hyperintensities, which are linked to cognitive decline and dementia. Interestingly, the study noted that sedentary behavior at work did not have the same negative impact on brain health, suggesting that the passive nature of television watching might be a key factor. The study was conducted over two decades and involved brain MRI scans to assess the long-term effects of television viewing on brain health.

NIH Study Reveals Midlife Brain Immune Shift Linked to Aging and Alzheimer's

NIH Study Reveals Midlife Brain Immune Shift Linked to Aging and Alzheimer's

A study funded by the National Institutes of Health (NIH) has discovered a significant shift in the immune environment of the hippocampus, a brain region crucial for learning and memory. This shift begins around age 50 and may contribute to the persistent brain inflammation seen in neurodegenerative diseases like Alzheimer's. Researchers found that microglia, the brain's primary immune cells, decline from age 50 to 75, replaced by cells with stronger inflammatory signals. The study utilized advanced single-cell methods to analyze postmortem hippocampal tissue, revealing changes in immune cell identity and origin that were previously hidden.

Swedish Neuroscientist Challenges Long-Held Belief on Adult Brain Neurogenesis

Swedish Neuroscientist Challenges Long-Held Belief on Adult Brain Neurogenesis

In 1998, Swedish neuroscientist Peter Eriksson, alongside Fred Gage from the Salk Institute, published groundbreaking research indicating that adult human brains can generate new neurons. This discovery was based on tissue samples from cancer patients who had been injected with a DNA tracer, revealing newly dated cells in the hippocampus. The study challenged the long-standing belief, established by Santiago Ramón y Cajal, that adult brains do not produce new neurons. Despite initial skepticism, subsequent research has supported Eriksson's findings, although debates continue regarding the extent and significance of adult neurogenesis.

Japanese Study Analyzes Therapeutic Window for Alzheimer's Disease Treatments

Japanese Study Analyzes Therapeutic Window for Alzheimer's Disease Treatments

A study based on the Japanese Alzheimer's Disease Neuroimaging Initiative (J-ADNI) has analyzed the therapeutic time window for disease-modifying therapies (DMTs) like lecanemab and donanemab in early Alzheimer's disease. The study found that baseline cognitive performance, measured by the Mini-Mental State Examination (MMSE) and Clinical Dementia Rating Global Score (CDR-GS), significantly influences the duration of eligibility for these treatments. The research highlights the importance of timely access to DMTs and suggests that better baseline cognitive scores predict a longer eligibility window.

Dr. Hazel Wiley's Alzheimer's Treatment Shows Promise in Clearing Brain Plaques

Dr. Hazel Wiley's Alzheimer's Treatment Shows Promise in Clearing Brain Plaques

Scott Milinsky, a 79-year-old resident of Pompano Beach, Florida, has experienced significant progress in his battle with Alzheimer's disease through a new treatment. Under the care of Dr. Hazel Wiley at Broward Health North's Memory Disorder & Alzheimer's Center, Milinsky was the second person in Florida to receive Kisunla, an anti-amyloid medication developed by Eli Lilly. This medication targets and breaks up amyloid plaques in the brain, which are a hallmark of Alzheimer's disease. Over a year and a half, Milinsky underwent 18 infusions, and his final PET scan confirmed the removal of these plaques. While the treatment is not a cure, as it does not address TAU tangles, Dr. Wiley considers the results significant, offering hope for slowing cognitive and functional decline in Alzheimer's patients.

Study Links Nearly Half of Dementia Cases to Modifiable Risk Factors

Study Links Nearly Half of Dementia Cases to Modifiable Risk Factors

A study conducted by Lund University has found that nearly half of dementia cases may be linked to modifiable risk factors such as smoking, high blood pressure, and cardiovascular disease. The research tracked brain changes in nearly 500 participants over four years, focusing on how these risk factors contribute to Alzheimer's disease and vascular dementia. The study highlights the potential for healthier lifestyle choices to delay the onset of dementia by reducing harmful brain changes. Researchers observed that modifiable factors were associated with damage to the brain's blood vessels and a faster accumulation of white matter changes, which are linked to vascular dementia.

Tau Protein's Role in Mitochondrial Dysfunction Linked to Neurodegenerative Diseases

Tau Protein's Role in Mitochondrial Dysfunction Linked to Neurodegenerative Diseases

Researchers from Stanford University and the University of California, San Francisco, have discovered a new mechanism by which the tau protein, associated with neurodegenerative diseases like Alzheimer's, affects mitochondrial function. The study found that phosphorylated tau can enter mitochondria and disrupt the electron transport chain, leading to reverse electron transport (RET) and increased production of reactive oxygen species (ROS). This process contributes to neurodegeneration and is independent of the traditional pathways involving neurofibrillary tangles. The findings suggest that RET may be a common pathogenic mechanism linking tau abnormalities to mitochondrial dysfunction across various diseases.